Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546454 · ClinicalTrials.gov registry record · NA
Relationship Between the Menstrual Cycle and Heart Disease in Women
A NA study of Coronary Heart Disease, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01546454 is a NA study of Coronary Heart Disease that has completed, run by Oregon Health and Science University. The registered enrollment target is 5 participants, below the 1,488-participant average among 19 other Coronary Heart Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01546454, a NA study of Coronary Heart Disease, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Women who have regular menstrual cycles have a lower risk of heart disease than men of the same age or women who no longer have menstrual cycles. The purpose of this study is to help determine why the menstrual cycle causes a lower risk of heart disease. The investigators believe that the hormones (estradiol and progesterone) produced during the menstrual cycle, as well as the normal processes occurring in the follicle and corpus luteum (transformed follicle), change levels of "good" and "bad" cholesterol in the blood-stream. These levels of good and bad cholesterol are an important risk factor for heart disease. Therefore, our goal is to determine what effects each of these factors (estradiol, progesterone, follicle, corpus luteum) have on the levels of good and bad cholesterol in the woman's bloodstream. As many women take birth control pills, which contain synthetic forms of estradiol and progesterone that block ovulation and development of a corpus luteum, the investigators also want to determine what effect one common type of birth control pill has on levels of good and bad cholesterol.
Conditions Studied
Interventions
- DRUG Progesterone
- DRUG Estradiol
- DRUG leuprolide acetate
- DRUG Ethinyl Estradiol-Levonorgestrel combination
Study Locations (1)
Oregon
- Oregon Health & Sciences University, Department of Obstetrics and Gynecology, Women's Health Research Unit - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546454
The ClinicalTrials.gov registry entry for NCT01546454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,488-participant average among 19 other Coronary Heart Disease trials with a reported enrollment target (100% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Heart Disease appearing as the primary indexed condition, and to 4 interventions - of which Progesterone is the first listed.
NCT01546454 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01546454 about?
NCT01546454 is a clinical study titled "Relationship Between the Menstrual Cycle and Heart Disease in Women". Women who have regular menstrual cycles have a lower risk of heart disease than men of the same age or women who no longer have menstrual cycles. The purpose of this study is to help determine why the menstrual cycle causes a lower risk of heart disease. The investigators believe that the hormones (...
What is the current status of trial NCT01546454?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-02. Estimated completion is 2013-01.
What conditions does trial NCT01546454 study?
This clinical trial studies the following conditions: Coronary Heart Disease.
What interventions are being tested in trial NCT01546454?
The interventions under investigation include: Progesterone (DRUG), Estradiol (DRUG), leuprolide acetate (DRUG), Ethinyl Estradiol-Levonorgestrel combination (DRUG).
Who is sponsoring clinical trial NCT01546454?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01546454 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Project 3: ACHIEVE- CHD
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
COMPLETED · NA
-
An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)
COMPLETED · NA
-
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
COMPLETED · NA
-
Walnut Consumption, Endothelial Function, and Biomarkers
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.